Seattle, WA -- (SBWIRE) -- 03/21/2017 -- The report "Patient Handling Equipment Market Product (Wheelchair, Scooters, Medical Beds, Bathroom Safety, Mechanical, Ambulatory), Type of Care (Bariatric Care, Critical Care, Wound), Accessories (Lifting, Transfer) & by End User (Home, Hospital) - Forecast to 2021", The patient handling equipment market is expected to reach USD 17.18 Billion by 2021 at a CAGR of 10.5% during the forecast period (2016–2021).

Browse 137 market data tables with 69 figures spread through 201 pages and in-depth TOC on "Patient Handling Equipment Market"
http://www.marketsandmarkets.com/Market-Reports/patient-handling-equipment-market-186358368.html
Early buyers will receive 10% customization on this report.

This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the patient handling equipment market along with estimates and forecasts of market revenue.

Factors driving market growth include the increasing incidence of disabilities, growing geriatric population, high risk of injuries to caregivers during manual handling of patients, and the implementation of regulations against manual lifting of heavy loads. On the other hand, the lack of training provided to caregivers is the major market restraint.

Download PDF Brochure@
http://www.marketsandmarkets.com/pdfdownload.asp?id=186358368

On the basis of type, the vaccines market is segmented into monovalent vaccines and multivalent vaccines. The monovalent vaccines segment is expected to account for the largest share of the global vaccines market in 2016 due to rising prevalence of diseases and increasing government and non-government initiatives for vaccine R&D activities.

Disease indication, included in the vaccines market are pneumococcal disease, influenza, diphtheria, tetanus, and pertussis (DTP), hepatitis, rotavirus, varicella, meningococcal disease, polio, measles, mumps, and rubella (MMR), human papilloma virus (HPV) infection, and others. The pneumococcal disease segment is expected to account for the largest share of the global vaccines market in 2016. High incidence of pneumococcal infections is driving the growth of this market.

Request For Customization Of This Report:
http://www.marketsandmarkets.com/requestCustomization.asp?id=186358368

End-users, included in the vaccines market are pediatrics and adults. The pediatrics segment is expected to account for the largest share of the global vaccines market in 2016. Increasing prevalence of diseases in children and rising number of awareness programs to promote vaccination will drive the growth of this market.

Based on regions, the global vaccines market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by increasing government funding for vaccine research and immunization.

About MarketsandMarkets
MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. For more information, please visit www.marketsandmarkets.com

Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No: 1-888-600-6441.